The RCVS Disciplinary Committee has this week directed that the name of a Grimsby veterinary surgeon should be removed from the RCVS Register, having found him guilty of serious professional misconduct for advising and undertaking surgical procedures without sufficient clinical grounds or considering alternative treatment options; failing to obtain the informed consent of his clients; undertaking procedures outside his area of competence; failing to refer or discuss the option of referral to a specialist; and, failing to provide his patients with adequate pain relief.
Mr Joseph Lennox Holmes, of Waltham Veterinary Clinic, Grimsby, faced nine charges relating to two separate complaints, at a two-week hearing in October which resumed this week.
These complaints concerned four consecutive staphylectomies and a tracheostomy that Mr Holmes performed on Jake, a Cavalier King Charles Spaniel owned by Ms Marsden; the dental treatment he gave to three Persian cats called Dream Topping, Charlie Brown and Henry, together with the advice he gave to their owner, Mrs Auckland.
On 25 October 2007, Mr Holmes performed a staphylectomy on Jake during dental surgery. He gave the Committee various reasons why he thought the procedure was necessary; however, the Committee accepted the opinion of two expert witnesses Professor Dan Brockman, a specialist in soft tissue surgery at the Royal Veterinary College, and Mr Andrew Ash, the senior veterinary surgeon at a 17-vet small animal practice, that there were insufficient clinical grounds for such a surgical procedure to be undertaken. The Committee also found Mr Holmes had not adequately considered other treatments, or obtained fully informed consent from Jake's owner for this procedure.
Mr Holmes performed further staphylectomies and a tracheostomy on Jake, a procedure described by Professor Brockman as "by definition, high risk and best performed by a specialist". He did not consider referral, or inform Mrs Marsden that such referral was an option. Nor did he provide sufficient aftercare or pain relief. Following these surgeries, Jake was euthanased .
In the second complaint, Mr Holmes performed dental extractions on two cats, Dream Topping and Henry, and advised removing teeth from a third, Charlie Brown, in October 2008. The Committee, however, accepted the view of expert witness Mr Ash and Dr David Crossley, RCVS Recognised Specialist in Veterinary Dentistry, that the dental extractions performed, and the advice given, were not justified on the available clinical evidence. The Committee also found that Mr Holmes did not discuss alternative treatment options with Mrs Auckland, or obtain her informed consent. In the case of Dream Topping, consent was sought after the cat had been sedated for an unrelated procedure and Mrs Auckland had felt under pressure to consent.
Mr Holmes had also relied on anaesthesia-inducing drugs to provide analgesia for the dental extractions, without any other form of pain relief. The Committee agreed with the expert witnesses that this was wholly inadequate.
The Committee found many aggravating factors in both cases, including actual injury to animals from unnecessary surgery, and a serious breach of the trust in which Mr Holmes' clients had placed in him to make the welfare of their animals his primary consideration. His repeated misconduct had been sustained over a period of time in the face of a previous adverse finding of the Committee in 2006.
It also found that Mr Holmes failed to appreciate when a case was outwith his experience, and had continued his course of action despite Jake's deterioration; he had not considered referral or accepted that others in the profession might know more than he did; in formulating clinical practice and policies, he made no reference to peer-reviewed literature or continued professional development; and, his use of outmoded drugs and medicines intended for human use was of concern, as was his lack of appreciation of the need for adequate pain relief when performing painful surgical procedures.
Towards the end of the hearing, Mr Holmes said in mitigation that he regretted unreservedly any adverse effects that his treatment had had on the animals concerned, and that he now realised that his long history of working alone had allowed him to become professionally isolated, to become over-confident in the value of his own experience and rather "set in his ways".
Having given serious consideration to postponing judgment, subject to undertakings from Mr Holmes, Disciplinary Committee Chairman Mrs Caroline Freedman said: "We are mindful that the sanction which we apply must be proportionate to the nature and extent of the misconduct found proved and must balance the public interests against the interests of the Respondent.
"We are, however, also mindful of Mr Holmes' conduct during the previous 11½ days of the hearing, during which time his every action was vigorously defended and no insight whatsoever was shown."
The Committee also considered suspending Mr Holmes from the Register. "In view of the serious and long-term nature of the conduct found proved in the charges, we do not feel that it is appropriate that Mr Holmes should be permitted to return to the Register without further assessment of his efforts to update his knowledge," said Mrs Freedman, before concluding: "The only appropriate sanction in each case is that the Registrar be directed to remove Mr Holmes' name from the Register."
A survey carried out in 2008 by the British Veterinary Association and its student branch, the Association of Veterinary Students (AVS) has found that that one in three students find themselves in difficult or severe financial situations, more than half have suffered from stress, over a fifth from depression, over a quarter from anxiety and one in every 14 from an eating disorder.
The survey also found that some veterinary schools have almost doubled their intake of overseas veterinary students since the survey was last conducted in 2005.
Other key findings from the survey included:
The AVS suggests that there are opportunities for veterinary schools and the veterinary profession to improve the bleak financial picture for students. BVA already provides support meetings for young professionals and has put together a position statement which will kick-start a lobbying process for:
BVA President Nicky Paull said: "The BVA/AVS survey, a part of the BVA's continuing work on behalf of veterinary students, once again continues to highlight the growing problem of debt. This is a particular problem for veterinary undergraduates whose five year course by definition will attract more debt than the average three year undergraduate course.
"The impact of this increasing debt is twofold. Firstly, new graduates are more likely to choose their first jobs on the basis of salary and reducing debt rather than individual professional development. Secondly, we are concerned that as school leavers make career decisions on financial grounds, only those from relatively affluent backgrounds will choose the veterinary profession. This is contrary to the aims of Government to promote the DfES/Gateway to the Professions initiative. It would be sad to see such a vitally important undergraduate course become one which can only be undertaken by talented young people from families who feel they can afford to help with the long term costs.
"The veterinary undergraduate course is not only training future veterinarians on animal health and welfare but also in the essential role vets play in food safety and the health of the nation."
The full survey results can be downloaded here.
Boehringer Ingelheim Vetmedica has launched Equisolon 33 mg/g oral powder, the first licensed oral prednisolone for the alleviation of inflammation associated with recurrent airway obstruction (RAO), otherwise known as heaves, in horses.
Clare Turnbull, equine brand and technical manager at Boehringer Ingelheim Vetmedica said: "Oral glucocorticoids are sometimes necessary for treating the inflammation associated with RAO. We feel it is important that when our customers need to use prednisolone for their cases, there is an equine specific product available to them that is easy to dispense and administer."
The company says Equisolon should be used in combination with environmental measures to treat RAO.
For further information on Equisolon, contact your Boehringer Ingelheim Vetmedica equine representative or call +44 (0)1344 746959.
The new guidance will remove the absolute requirement for veterinary surgeons to perform a physical examination before prescribing POM medicines, making it instead a matter for your professional judgement.
However, the proposed new guidance also imposes a requirement for veterinary surgeons who do NOT physically examine the animal prior to prescribing to provide a 24/7 follow-up service which includes a physical examination.
Furthermore, the new guidance will state that: "Where the veterinary surgeon is not able to provide this service [the physical exam] themselves, they should arrange for another veterinary service provider to do so. This arrangement should be made before veterinary services are offered and confirmed in writing as part of the conditions of service agreed by the client."
This requirement to provide a physical 24/7 follow-up would appear to safeguard animal welfare and protect against the risk of online-only businesses (in the UK or abroad) with lower overheads cherry-picking the job of prescribing medicines.
It should also protect against veterinary surgeons feeling pressured to prescribe inappropriately, because the new, stricter requirements will make it easier for them to decline to do so.
However, the BVA doesn't agree with the new proposals. It feels that remote prescribing should be delivered under the auspices of a Veterinary Client-Patient-Relationship (VCPR), which, according to the American Veterinary Medical Association, requires a physical examination.
BVA President Malcolm Morley, said: “The changes to ‘under care’ guidance are a watershed moment, so it’s positive to see that they have evolved in response to feedback from the profession. New technology presents exciting opportunities to enhance existing veterinary services and has benefits for practices as well as clients and their animals.
"However, BVA has been very clear that we believe remote prescribing can only be safely delivered where a vet-client-patient relationship has been established.
"This is an internationally recognised concept, and we are disappointed that the RCVS has decided not to embrace it.
“Having voted to implement these changes, it is incumbent upon the RCVS and the profession to scrutinise how they play out.
"At BVA we plan to develop advice and resources to support our members and help them comply with the new guidance and realise any benefits of remote veterinary service provision.’
“It is now vital that a timeframe for a review is quickly put in place, so any negative impacts on animal welfare or the sustainability of veterinary services can be dealt with swiftly.”
Council voted by a majority of 20 to 3 in favour of the changes, which it then decided should come into force between 1st June and 23rd December 2023, subject to a review at the next meeting.
Discuss here.
Boehringer Ingelheim has announced that Vetmedin Chewable Tablets have been licensed for treating pre-clinical dilated cardiomyopathy (DCM) in Doberman Pinschers1.
Boehringer says DCM is the most common form of cardiomyopathy in dogs and the second most common form of acquired heart disease in dogs. Typically, up to half (25 - 50%) of Doberman Pinschers develop DCM in their lifetime and before congestive heart failure (CHF) develops, over a quarter (25 - 30%) of these dogs will suffer sudden death. Despite optimal treatment, survival time once in CHF is short at just 2 - 4 months, with a fatality rate of at least 90% after a year.
The new indication was granted following a study which showed that early intervention with Vetmedin at pre-clinical stages in Dobermans can significantly delay the onset of CHF, increasing life expectancy and quality of life for patients2.
Robert Lucy, Vetmedin brand manager, Boehringer Ingelheim UK, said: "The PROTECT study, and the resulting new indication for Vetmedin is groundbreaking. For the first time ever, we are now not only able to manage congestive heart failure, but to significantly delay it. By acting sooner, we'll be able to alter the course of disease progression, ultimately increasing survival and allowing more pet owners to spend more time with their beloved dogs. Key to this will be giving vets the support and confidence in recognising the subtle signs of pre-clinical DCM. We plan to support veterinary professionals with new educational materials, including a screening algorithm, to help the diagnostic process."
Traditionally, there have been no licensed therapies available to vets to slow the progression of heart disease during the pre-clinical stage. However, peer-reviewed independent data from PROTECT, the first study in veterinary cardiology of its kind, proves that early intervention with Vetmedin at pre-clinical stages in Dobermans Pinschers can significantly delay the onset of CHF, increasing life expectancy and quality of life for patients.
Cancer Care for Pets offers both clinical and palliative care for pets with cancer, supporting the work of the first opinion team at Donaldson's and taking referral cases from far and wide.
Neil and Kirsty have worked in practice together in the Yorkshire area for seven years, working with owners and families to create treatment plans involving diagnostic investigations, specialised imaging, surgery, chemotherapy and palliative care.
Neil said: "As far as we know, we are one of very few services to offer this combination of veterinary and nurse-led consultations, where comprehensive cancer treatment and care plans are developed together with owners. We have worked hard to instil our team approach where, following surgery and treatment, the Cancer Care team, the owner and the referring practice are all involved in the pet’s ongoing care and wellbeing."
Kirsty said: “Neil and I do many of our consults together. Neil will give his clinical overview and I will help owners to process and understand the treatment and the next steps for their pet.
“It was incredibly important to us to create a friendly, welcoming environment in our new dedicated consultation area at the hospital. We need people to trust us and be honest about how fit and well their pet really is, in the knowledge we are not automatically going to tell them there is nothing we can offer them. Treating cancer is about life, not managing a death, and making sure that the pet’s life – even if it is limited – is as good as it can be.”
Neil said: "The Cancer Care for Pets team will be working alongside the wider Donaldson’s veterinary and nursing teams and we are keen to learn from each other. The facilities at the hospital are second to none, particularly our new purpose-built consultation area, the practice’s new CT scanner and the high spec operating facilities. Donaldson’s also has a well-respected rehabilitation and pain clinician with whom we can work closely to help our older patients to keep mobile, flexible and maintain activity levels.”
Neil and Kirsty are supported by a third member of the Cancer Care for Pets team, oncology nurse Jenna Carrick RVN.
Cancer Care for Pets is now accepting referrals. Contact: info@cancercareforpets.co.uk or 01484 242911.
Mark, an Advanced Practitioner in Zoological Medicine, is well known in the profession, having lectured in the UK and internationally, as well as having numerous articles on exotic topics published in peer reviewed veterinary journals.
Mark said: “I’m really pleased to be joining Pennard Vets, which has seven sites across Kent, and is owned by its employees, which made it a particularly attractive place to join, as I now also own a stake in the business and can help shape the future of it. I can’t wait to meet our clients and their pets and hope to make a real difference to their lives.”
Andy Green, Director at Pennard Vets, said: “Mark is the most qualified vet in the South East of England working in exotics, and we are delighted he is bringing so much experience to Pennard Vets.
"We hope to become the go-to practice for all exotic pets in the South-East and believe that our new and existing clients will all benefit from Mark’s unique and thoughtful approach to veterinary care.”
www.pennardvets.com
The Group has trained almost 100 of its staff as 'mental health first aiders'.
Michelle O’Connor, the Linnaeus Group’s people and culture director (pictured right), said: "Veterinarians are three to four times more likely to die by suicide than workers from any other industry.
"Because of this alarming statistic, we have put wellbeing at the very forefront of our strategy and have so far trained nearly 100 mental health first aiders within the group.
The Linnaeus volunteers, who are taken from both office and clinical roles, have all attended a training course run by Mental Health First Aid England (MHFA) to acquire the skills to support their own and others’ wellbeing.
The MHFA course trains people to identify the signs of mental ill health, to break down the stigma and barriers surrounding mental health and listen to colleagues in a non-judgemental way, and to help direct those suffering from issues to the support and guidance that’s available.
Michelle added: "We realise training on how to spot signs of a crisis and become a mental health first aider alone does not address the prevailing stigma around mental health in the workplace.
"So, in addition, we are developing a culture where support and conversations about mental health are normalised, so that colleagues feel able to reach out for the important support they need."
The RCVS Disciplinary Committee has agreed to adjourn multiple charges against an Essex-based veterinary surgeon who qualified in 1969, following his undertakings firstly to request removal from the RCVS Register and secondly never apply to be restored to it.
At the hearing, which had originally been listed for seven days, Geoffrey Raymond Oliver, 68, was charged with serious professional misconduct over allegations of his inadequate treatment of two dogs and a cat (belonging to three different clients) between 2010 and 2012; inadequate record keeping; failures to deal honestly or properly with his clients; and, failure to heed advice from the RCVS Preliminary Investigation Committee about the importance of proper communication between veterinary surgeons and their clients.
However, before the Committee heard evidence on any aspect of these charges, Mr Oliver lodged his application for adjournment. The Committee therefore made no findings on the charges, and emphasised they had neither been proved against, nor admitted by, him.
The Committee noted that there had been no adverse findings against Mr Oliver during his professional career, that his practice was now closed and that he had no intention of returning to practise in the future. Should he subsequently apply to be restored to the Register, the Committee would resume its consideration of the charges, along with his breach of the undertaking.
The Committee was advised that none of the complainants in the case - which could have incurred considerable time and costs - dissented from the proposed course of action.
Speaking on behalf of the Disciplinary Committee, its Chairman, Professor Peter Lees, said: "The Committee has concluded that no useful purpose would be served were it to insist on a full hearing [and it] would be a disproportionate waste of...resources [to do so]. The Committee is satisfied that [granting the adjournment application] protects the welfare of animals and...is in the public interest."
The Committee then accepted Mr Oliver's undertakings, including the removal of his name from the Register with immediate effect.
Professor Lees added: "So that he is in no doubt about the matter, the Committee reminds [Mr Oliver] that, when referring clients of his former practice elsewhere, he should be careful to avoid giving them any advice about the diagnosis or treatment of their animals."
Researchers from Nottingham Trent University and the Royal Veterinary College found that exertion or exercise – which could include dogs walking, playing or running with their owners – was responsible for three quarters (74%) of heat stroke cases. Many of these cases were in the summer months.
For the study, the researchers analysed the clinical records of more than 900,000 UK dogs. They found that 1,222 had received veterinary care for heatstroke at some point during their lives, almost 400 affected in a single year. 14.2% of them died as a result of their heatstroke.
Hot weather alone was responsible for 13% of cases, while travelling or being left in hot vehicles accounted for 5% of cases. Other triggers for heat stroke included undergoing treatment at a veterinary surgery or a dog grooming parlour, being restricted to hot buildings or trapped under blankets.
Male dogs and younger dogs were more likely to develop heatstroke triggered by exercise, with breeds including the Chow Chow, Bulldog, French Bulldog, Greyhound, English Springer Spaniel, Cavalier King Charles Spaniel and Staffordshire Bull Terrier at increased risk.
Older dogs and brachycephalic breeds, such as bulldogs and pugs, were at increased risk of getting heatstroke just by sitting outside in hot weather. Brachycephalics were particularly at risk of developing heat stroke if left in hot cars.
Emily Hall, a researcher and veterinary surgeon in Nottingham Trent University’s School of Animal, Rural and Environmental Sciences said: "It appears that people are hearing the message about the dangers of hot vehicles, but campaigns to raise public awareness about heat-related illness in dogs need to highlight that dogs don’t just die in hot cars. Taking a dog for a walk or a run in hot weather can be just as deadly so consider skipping walks altogether during heatwaves, or be sure to take dogs out early in the morning whilst it’s still cool.
Dr Dan O’Neill, co-author and senior lecturer in companion animal epidemiology at The Royal Veterinary College, said: “The UK is currently in the midst of an ill-fated love affair with flat-faced dogs. Demand for breeds such as the French Bulldog, Pug and British Bulldog has soared during the Covid19 lockdown. I appeal to owners to put the needs of the dog ahead of their own desire to possess something that looks cute."
Reference
EthyCalm is sprayed directly on the skin, or, for more fractious patients, can be applied with a swab.
Invicta says that unlike other products the effect is instant and EthyCalm leaves no residue on the skin surface.
The improved product, EthyCalm Plus, contains 50% more product (good for over 100 applications) and incorporates a new 'on-off' switch for easier application. It is also now packed in a 'no-roll' case to protect from damage.
Rob Watkins, Managing Director of Invicta, said: "EthyCalm has been an incredibly popular product with nurses and vets. As a small company we always listen to our customers and have taken the opportunity to incorporate suggestions for improvement. The result is EthyCalm Plus which offers significant enhancement over the original product".
EthyCalm Plus is available from veterinary wholesalers and for a limited time the price has been held at £25 each.
The group’s Board, led by outgoing president, Renay Rickard and incoming president, Julie Beacham, decided to change the trading name to better reflect the diverse nature of the organisation’s membership and promote inclusivity.
The VMG says that in parallel with evolving models of veterinary business management, it has seen its membership expand to include clinical and non-clinical team members from practice, as well as those from industry and academia.
Renay said: "We are seeing a trend where the veterinary practice manager role is now complemented by - and in some cases superseded by - tiers of team leaders, many with management responsibilities and interests.
"This is reflected in our membership, which is increasingly diverse – we have growing numbers of members from the clinical side of practice, such as head nurses and vet team leads, as well as involvement from front-of-house and administration teams. In larger group practices, we have operations staff, marketing managers, finance teams and so on all joining up.
"Part of the success of our organisation is that we have attracted and catered for these diverse roles. Our New to Management series of CPD webinars last year was one example, and we will build on this in 2018, adding in new content. 2018 will also see a new structure for our regional group meetings, with roadshows and day events.
"This diversity in membership brings vibrancy and new ideas with it, vital to the life-blood of any organisation. Our aim is to be inclusive and cater for the needs of anyone with an interest in management through development and support."
The VMG has also launched a new website, www.vetmg.com with a private members’ area which offers various resources, from CPD to protocols.
Protexin has announced that preliminary data from a clinical trial supports the use of Denamarin® to protect against lomustine (CCNU)-induced hepatotoxicity in dogs.
The study is being performed at the University of California-Davis, Veterinary Medical Teaching Hospital, and the initial results were recently presented at the American College of Veterinary Internal Medicine (ACVIM) Annual Forum. Marketed in the UK by Protexin, Denamarin is the combination of S-adenosylmethionine (SAMe) and silybin.
According to the company, most dogs treated with the chemotherapeutic agent CCNU experience liver enzyme elevation. Elevation of certain liver enzymes such as alanine transferase (ALT) is a key indicator of liver trauma; significant enzyme elevation may lead to a discontinuation, delay, or reduction in chemotherapy. The ongoing clinical trial was designed to evaluate Denamarin as a hepatoprotectant in dogs diagnosed with neoplasia that are undergoing CCNU therapy.
The trial consists of two groups of randomly assigned dogs. Dogs in Group 1 receive Denamarin beginning at the start of CCNU therapy. Group 2 dogs do not receive Denamarin unless they develop a Grade IV hepatotoxicity.
Results of a planned interim analysis completed on the first 30 dogs enrolled revealed that starting Denamarin when CCNU therapy was instituted (Group 1 dogs) appeared to provide hepatoprotection. While the mean post-therapy ALT elevation for Group 1 was 119 IU/L (p=0.1), for Group 2 dogs, the post-therapy ALT level was 815 IU/L (p=0.046). Chemotherapy was altered due to elevated liver enzymes in three Group 2 dogs but only one dog in Group 1.
Janine Barlow, Technical Manager at Protexin said: "We are extremely pleased by the initial findings of this research. The use of Denamarin with chemotherapy looks to help protect liver function allowing for successful completion of therapy and hopefully a longer, happier life for the pet. We look forward to the results of the full study."
Protexin says the SAMe and silybin in Denamarin support and maintain hepatic function by mechanisms including increasing levels of glutathione, the liver's main detoxifying agent; promoting protein synthesis; and stimulating bile flow. Denamarin is useful as part of a polymodal approach to the management of liver health.
Denamarin is available for both dogs and cats in an enteric-coated tablet.
Virbac points to research showing that MCTs are the most common form of skin cancer in dogs, accounting for up to 21% of skin cancer cases1.
This, says the company, means that understanding the challenges surrounding mast cell tumour diagnosis, work up (including the various prognostic panels) and treatment selection for mast cell tumour cases is vital.
The session, entitled ‘Fundamentals of Mast Cell Tumour Management’, will conclude with a review of Stelfonta, walking through cases and how to get the best results.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "We know that vets are facing webinar fatigue.
"We therefore hope that this brand new style of online learning on one of the most common canine cancers will be more engaging, whilst still delivering high quality CPD."
To register for the live event, visit: https://tinyurl.com/mct-masterclass
For more information, speak to your Virbac Territory Manager, or visit vet-uk.virbac.com/stelfonta
Cosacthen contains 0.25 mg/ml of tetracosactide which had only previously been available as human-registered or compounded veterinary ‘special’ preparations meaning availability and cost could be unpredictable.
Tetracosactide is used in the ACTH stimulation test to assess the adrenocortical function of patients with endocrine diseases, such as Cushing’s and Addison’s.
Dechra Brand Manager Claire Morgan said: “As experts in endocrinology, we recognise that the testing involved in adrenal conditions can be a costly process for pet owners, which can mean that some cases don’t progress to treatment or have their treatment optimised.
"The launch of Cosacthen gives veterinary surgeons the reassurance associated with a veterinary licensed medicine. As these cases can appear on an irregular basis, Cosacthen is ideal to keep in the practice ready for when a case is presented making it a cost-effective solution that can help offset the cost for owners of long-term treatment of adrenal conditions."
Cosacthen is available in 1 ml single-use vials.
For more information visit www.dechra.co.uk/cosacthen.
The five talented winners of the "Vets in your daily life" competition were announced today by DG SANCO, the European Commission's Directorate General for Health and Consumers and the World Organisation for Animal Health (OIE).
DG SANCO launched the worldwide photography competition earlier this year, to coincide with World Vet Year 2011, celebrating the 250th anniversary of the veterinary profession. The five winners are: Somenath Mukhopadhyay (Winner for Asia), Genoveva Kriechbaum (Winner for Middle East), Molly Feltner (Winner for Africa), Ariel Alejandro Corvalán Herrera (Winner for the Americas) and István Konyhás (Winner for Europe). István Konyhás, European winner and leader of the Hungarian Working Group of Cranes said: "The photo I took in Hortobagy's Bird Hospital (a foundation set up for healing injured wild birds) highlights the care put into healing an injured stork. It also reflects the meticulousness of Dr János Déri trying to re-instate the lost parts of the stork's beak with dental treatment. As a volunteer of the foundation I have taken photos of their work for years so I am pleased to be one of the winners and with the prize money, I hope to be able to take even more interesting and striking photos."
István Konyhás' winning photograph highlights the care put into healing an injured stork. © European Commission.Molly Feltner, African winner and Communications Officer for the Mountain Gorilla Veterinary Project (MGVP) commented: "I am delighted to be one of the winners of this photo competition and am particularly proud of what this photos highlights. Working with the MGVP in Rwanda, Uganda and the Democratic Republic of Congo (DRC) we are dedicated to saving the lives of mountain gorillas. This photo beautifully depicts the doctor-patient relationship between MGVP's veterinarians and gorillas."
Molly Feltner's winning photograph depicts the relationship between Mountain Gorilla Veterinary Project veterinarians and gorillas. © European Commission.
Ariel Alejandro Corvalán Herrera's photograph won the Americas category. © European Commission.
The winning image for the Asia Pacific region was taken by Somenath Mukhopadhyay. © European Commission.
Genoveva Kriechbaum was the winner for the Middle East. © European Commission.
This year's Veterinary Week, from Monday 16th to Sunday 22nd May, aims to highlight the contribution of the veterinary profession to society under the slogan "Vets in your daily life." This includes a conference on 'Crisis Management in the Food Chain' (organised by the European Commission) today and tomorrow, during which Commissioner John Dalli will present the prizes to the regional winners of the international photographic competition organised jointly with the World Organisation for Animal Health (OIE). Events to celebrate Vet Week will be taking place across the European Union.
The students are being given the chance to treat cats, dogs and rabbits coming into the RSPCA centre under the supervision of its resident veterinary surgeon, Joanne Henstock.
The placement offers them valuable skills in dealing with animals which have received little or no veterinary care in the past and often arrive at the shelter in an extremely poor condition.
Ella Carpenter, RSPCA Animal Centre Manager, said: "The students are familiar with seeing pets which have been well cared for by their owners and it can be shocking for them to witness the state in which some of the animals arrive at our shelter.
"In particular, they see the, often life-threatening, impact it can have on an animal when it hasn’t received care considered to be fundamental veterinary medicine, such as flea or worming treatments.
"We commonly see animals that arrive with little or no medical history, so they can practice a back to basics, 'treat what we see', approach. And they learn about the challenges we face in providing the best possible care for large numbers of animals, many with complex medical needs, while working within the finite resources of a charity which relies entirely on public donations."
Malcolm Cobb, Professor of Comparative Veterinary Medicine and Deputy Head of the School of Veterinary Medicine and Science, said: "We are really excited to be working with the RSPCA at Radcliffe. There is a very large and varied case load for our students to assist with, learn from and help to manage, including some cases of neglect which they might not see elsewhere, and which can represent a significant clinical challenge."
Photo: Jo Henstock (Associate Vet RSPCA), Bramble the Beagle, Sophie Isaacs (Final Year Vet Student), © The University of Nottingham
Each OraStripdx comprises a dry porous pad, pre-treated with a mixture containing a thiol detection reagent, attached to a plastic backing.
The strip is gently swiped along the maxillary gingival margins, whereupon it changes colour from off-white to various intensities of yellow, representing the concentration of thiols present.
Animalcare says this visual result can support vets and veterinary nurses in explaining to owners the often-invisible early signs of periodontal disease, without the need to examine the animal under anaesthetic
Apparently, the WSAVA Global Dental Guidelines say that test strips have been shown to improve client compliance with dental recommendations.
Dr Colin Capner, Senior Technical Vet at Animalcare, said: “OraStripdx helps to prompt, and raise the profile of veterinary oral health conversations in practice, employing an easy to use, evidence based diagnostic test for periodontal disease that does not require a general anaesthetic.
"In demonstrating the presence of periodontal disease in dogs and cats to clients through a test strip colourimetric change, it bridges the gap between oral examination and the requirement for clinical veterinary intervention.
"Early detection of otherwise invisible periodontal disease will help to maintain good pet oral health and welfare, and facilitate awareness of the potential need for planned clinical treatments.”
On 30 November 2022, Animalcare is hosting a free webinar which demonstrates how OraStripdx can help drive positive oral health conversations.
You can sign up to the webinar at www.animalcare.co.uk/dentalwebinars.
The company has also created a range of dental care educational resources for veterinary healthcare team members and pet owners which are available for download at www.dental.pet.
The Society of Practising Veterinary Surgeons (SPVS) has published its 2014 Salaries Survey which showed that the gender pay gap has closed from 15% last year to 10.8% this.
However, the association notes that this is still slightly higher than the gap reported for all professions in the UK, so there remains work to be done.
The survey, which is the largest of its kind and drew responses from 1,878 vets, nurses, practice managers and receptionists also found that:
Peter Brown, SPVS Treasurer and author of the report comments: "The SPVS Salaries Survey is intended as a benchmark to give some indication of what is being paid as the 'going rate' rather than to advise on what employees should be paid. Having said that, we would urge all veterinary practices to continue working to ensure that equal rates of pay are given for positions of equal status. Although the gender gap has closed up, it is still too big."
The annual SPVS Salaries Survey is free of charge to SPVS members and costs £150 for non-members. For more information, call 01926 410454 or visit www.spvs.org.uk.
It is estimated that there are more than one million pet ferrets in the UK and a further 500,000 in the United States, but until now little was known about how ferrets are housed and what environmental enrichment they benefit from.
For the study1, RVC researchers analysed 750 responses to an online questionnaire from ferret keepers (82% of whom were pet owners and the remainder were from the laboratory, zoo, rescue and pest control sectors) from 17 countries.
The study found that most ferrets were housed with at least one other ferret, providing social interaction.
The environmental enrichments that ferret keepers believed their ferrets most enjoyed were tunnels (42.5%), digging (27.3%), human interaction (20.8%) and exploration (17.6%).
The items reported as being most problematic included rubber toys, which can cause internal blockages when chewed and swallowed (45.1%) and enrichments which can result in claws or other body parts becoming trapped, such as narrow tunnels and certain fabrics including fleece, towels and loosely woven fabrics (28.6%).
Other main findings included:
Alice Dancer, PhD Student at the RVC, and lead author of the paper, said: “How animals are housed and the environmental enrichment they are given can have a significant impact on their health and wellbeing.
"The finding that large housing and high numbers of enrichment are possible in all ferret-keeping sectors is a really good sign for ferret welfare.
"We hope that these results help inspire ferret caretakers to consider the housing they use, offer ideas for new ferret enrichments, and raise awareness of enrichments which may harm their ferrets.”
The new bottle size will last approximately 100 days when treating an average sized cat of 4 kg.
Amy Scott, brand manager for Semintra said: "The new 100 ml bottle size will ensure that Semintra is even more convenient for owners, whilst facilitating long-term compliance that fits in well with recommended recheck intervals for CKD."
Cats with CKD have an overactive renin-angiotensin-aldosterone system (RAAS), which can lead to proteinuria and further progression of kidney disease. Semintra contains the active ingredient telmisartan – the only angiotensin receptor blocker (ARB) licensed for use in veterinary medicine. Boehringer says it provides targeted, long-lasting suppression of the RAAS1.
Semintra is a once daily oral liquid. Now available in both 30 ml and 100 ml bottle sizes, it has a six month shelf life after opening.
For further information on Semintra visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.
Mark, who graduated from Cambridge University in 1997, has a broad interest in internal medicine but particularly enjoys the challenges posed by gastrointestinal, endocrine, haematology and renal medicine.
He has a PhD in Neuroscience at the University of Cambridge and after completing his PhD he took a residency in Small Animal Medicine at Cambridge, followed by four years in a private specialist practice in the south of England.
Mark was then appointed Clinical Associate Professor in Small Animal Internal Medicine at the Nottingham Veterinary School, where he was responsible for running the final year medicine rotation along with lecturing to all years of the veterinary course.
He was also in charge of the school’s small animal intern and residency programmes in addition to supervising both undergraduate and post-graduate research students.
Mark has also been involved in national and international investigations into canine breed-related diseases such as canine cancer, canine and feline haematology, canine endocrine disease and the development of novel non-invasive biomarkers to help diagnose both simple and complex medical diseases.
Outside work, Mark is a seven-guitar-owning-musician, a race-winning cyclist and a keen runner with a personal best of one hour twenty five minutes for a half marathon. What a relief for the rest of us mere mortals to hear there's something he's rubbish at: he says he swims 'like a brick'.
Mark said: "I’m excited to be joining the outstanding team at Willows who deliver such exceptional care to pets and their owners and such an outstanding service to the referring veterinary surgeons.
"It is a wonderful opportunity for me and I’m really looking forward to making my own contribution to their continued success."
To enter the competition, VetSurgeon members just needed to post a 'top tip' that could in any way make life easier, quicker, better or happier for a colleague.
Making use of the new feature on VetSurgeon.org where members can click a link marked 'thank you' to show their appreciation of something useful shared by someone else, VetSurgeon offered five £50 Amazon Vouchers for the most thanked tips shared before the end of November.
The winners are:
Mark Rowland for his tip that Mikki Muzzles make great anaesthesia masks for guinea pigs.
Emma Robinson for her solution to the problem of opening a new bottle "that has one of those annoying little metal caps".
Kate Richardson for her tip, which was to use an elastic band to 'tie' your et tubes in.
Julie Innes for her suggestion to use an elastic/ Velcro back support wrap from the Pound Shop when doing hip scores.
Gillian Mostyn for things you can do with a latex glove.
Bonqat 50 mg/ml oral solution for cats contains pregabalin, an analgesic, anti-epileptic which has now been licensed for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.
Tessie 0.3 mg/ml oral solution for dogs contains tasipimidine and is licensed for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure.
Dômes Pharma points to research which shows that in the UK 1.4 million1 dogs show signs of distress when left alone, and 4.4 million dogs1 show fear of loud noises.
In addition, over 4 million cats2 are not having routine vet checkups each year, with 26%2 of these owners reporting that it is too stressful for their cat or themselves.
Jonathan Hill, UK country manager at Dômes Pharma sid: "Dômes Pharma is excited to be launching two new innovative products to help vets manage cases in this complex area.
"These products expand our portfolio and provide essential options for owners and their pets struggling with these situational related problems."
https://www.tvm-uk.com/the-behavioural-range
Royal Canin has launched two new skincare diets.
'Hypoallergenic Wet' is a wet adaptation of its 'Hypoallergenic' range of diets, providing variety for the nutritional management of dogs with adverse food reactions. 'Anallergenic' dry food is for the dietary management of dogs with even the most severe dietary allergy.
'Hypoallergenic Wet' contains soy protein hydrolysate, so it can either be fed as a complete diet or interchanged and used as an addition to Hypoallergenic, Hypoallergenic Moderate Calorie or Hypoallergenic Small Dog. The wet food, available in a 400g can, can be recommended for short term feeding (for an elimination diet strategy) or for the lifelong nutritional management of dogs with adverse food reactions. Royal Canin says it is designed to be highly digestible through its low molecular weight peptides and is also appropriate for the dietary support of dogs with inflammatory bowel disease, chronic diarrhoea and Exocrine Pancreatic Insufficiency (EPI).
'Anallergenic' follows in the footsteps of Hypoallergenic but goes further - offering both hydrolysed proteins and a pure carbohydrate source, to which exposure is limited and therefore allergy would be rare. The diet comprises a unique protein source composed exclusively of free amino acids and very low molecular weight oligopeptides. Much like the Hypoallergenic range, Anallergenic is also formulated with essential fatty acids to help support skin health and a complex of nutrients to help maintain the barrier effect of the skin.
The fully balanced diet - suitable for the nutritional support of adult dogs either short or long-term - has proven results with 100% of dogs in a Royal Canin study showing significant improvement in their skin condition.
Gudi Stuttard BVSc MRCVS, one of Royal Canin's Veterinary Support Managers, said: "These two new products join our well-established 'Hypoallergenic' range, as well as our recently launched 'Skin Care' diets - for the nutritional management of dogs with dermatosis unrelated to food intolerance or allergy.
"By building on our portfolio of veterinary skin care diets, we aim to further strengthen our DermAlliance campaign, which is dedicated to assisting in the improvement of skin care knowledge in general veterinary practice."
Please visit www.royalcanin.co.uk for more information.